ES2551459T3 - Método para producir un parche de ropinirol supersaturado - Google Patents

Método para producir un parche de ropinirol supersaturado Download PDF

Info

Publication number
ES2551459T3
ES2551459T3 ES14174708.9T ES14174708T ES2551459T3 ES 2551459 T3 ES2551459 T3 ES 2551459T3 ES 14174708 T ES14174708 T ES 14174708T ES 2551459 T3 ES2551459 T3 ES 2551459T3
Authority
ES
Spain
Prior art keywords
adhesive agent
agent layer
patch
ropinirole
supersaturated
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
ES14174708.9T
Other languages
English (en)
Inventor
Takahito Yoshizaki
Kouji Tanaka
Kazunosuke Aida
Terumitsu Kaiho
Nobuo Tsutsumi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hisamitsu Pharmaceutical Co Inc
Original Assignee
Hisamitsu Pharmaceutical Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hisamitsu Pharmaceutical Co Inc filed Critical Hisamitsu Pharmaceutical Co Inc
Application granted granted Critical
Publication of ES2551459T3 publication Critical patent/ES2551459T3/es
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404Indoles, e.g. pindolol
    • A61K31/4045Indole-alkylamines; Amides thereof, e.g. serotonin, melatonin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/70Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/14Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/14Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16Anti-Parkinson drugs

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Psychology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

Método para producir un parche que comprende una capa de soporte y una capa de agente adhesivo dispuesta sobre al menos una superficie de la capa de soporte, comprendiendo el método: etapa A) obtener una composición de capa de agente adhesivo que comprende ropinirol libre en una cantidad que da como resultado del 5 al 13,2% en masa en relación con la masa total de una capa de agente adhesivo obtenida; etapa B) calentar la composición de capa de agente adhesivo a una temperatura en un intervalo de desde 50 hasta 76ºC durante de 5 minutos a 24 horas; y etapa C) enfriar la composición de capa de agente adhesivo calentada hasta temperatura normal a una velocidad promedio de disminución de temperatura de 1 a 20ºC/hora, obteniendo de ese modo la capa de 1agente adhesivo que comprende el ropinirol libre a una concentración supersaturada en forma disuelta.
ES14174708.9T 2013-06-28 2014-06-27 Método para producir un parche de ropinirol supersaturado Active ES2551459T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2013137147 2013-06-28
JP2013137147A JP5415645B1 (ja) 2013-06-28 2013-06-28 貼付剤の製造方法、貼付剤及び包装体

Publications (1)

Publication Number Publication Date
ES2551459T3 true ES2551459T3 (es) 2015-11-19

Family

ID=50202791

Family Applications (1)

Application Number Title Priority Date Filing Date
ES14174708.9T Active ES2551459T3 (es) 2013-06-28 2014-06-27 Método para producir un parche de ropinirol supersaturado

Country Status (8)

Country Link
US (1) US9320728B2 (es)
EP (1) EP2818161B1 (es)
JP (1) JP5415645B1 (es)
KR (1) KR101516122B1 (es)
CN (1) CN104138366B (es)
CA (1) CA2855309C (es)
ES (1) ES2551459T3 (es)
TW (1) TWI488644B (es)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10716763B2 (en) 2015-04-15 2020-07-21 Hisamitsu Pharmaceutical Co., Inc. Transdermal patch containing ropinirole
WO2017006974A1 (ja) * 2015-07-08 2017-01-12 王子ホールディングス株式会社 経皮吸収型貼付剤
WO2017223402A1 (en) 2016-06-23 2017-12-28 Corium International, Inc. Adhesive matrix with hydrophilic and hydrophobic domains and a therapeutic agent
MX2019001104A (es) 2016-07-27 2019-10-02 Corium Int Inc Sistemas de suministro transdermico de memantina.
KR102406536B1 (ko) 2016-07-27 2022-06-08 코리움, 인크. 도네페질 경피 전달 시스템
CN110121344A (zh) * 2016-12-28 2019-08-13 久光制药株式会社 含布托啡诺的贴附剂
ES2971449T3 (es) 2017-02-24 2024-06-05 Hisamitsu Pharmaceutical Co Parche cutáneo adhesivo y producto envasado del mismo
JP6704514B2 (ja) 2017-04-25 2020-06-03 久光製薬株式会社 貼付剤
US10898448B2 (en) 2017-04-25 2021-01-26 Hisamitsu Pharmaceutical Co., Inc. Patch
DE102018120505A1 (de) 2017-10-20 2019-04-25 Amw Gmbh Verhinderung der Kristallisation von Wirkstoffen in transdermalen Darreichungssystemen
US11173132B2 (en) 2017-12-20 2021-11-16 Corium, Inc. Transdermal adhesive composition comprising a volatile liquid therapeutic agent having low melting point
JP7285790B2 (ja) * 2018-01-22 2023-06-02 株式会社カネカ 皮膚貼付用粘着シート

Family Cites Families (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH066534B2 (ja) 1986-10-09 1994-01-26 積水化学工業株式会社 経皮吸収貼付剤
US4832953A (en) 1987-08-13 1989-05-23 Alza Corporation Method for preventing the formation of a crystalline hydrate in a dispersion of a liquid in a monaqueous matrix
US5656286A (en) 1988-03-04 1997-08-12 Noven Pharmaceuticals, Inc. Solubility parameter based drug delivery system and method for altering drug saturation concentration
US5308621A (en) 1991-02-18 1994-05-03 Commonwealth Scientific And Industrial Research Organisation Ascorbic acid composition and transdermal administration method
GB9511366D0 (en) 1995-06-06 1995-08-02 Smithkline Beecham Plc Novel formulations
US5906830A (en) 1995-09-08 1999-05-25 Cygnus, Inc. Supersaturated transdermal drug delivery systems, and methods for manufacturing the same
US5807570A (en) 1995-09-29 1998-09-15 Cygnus, Inc. Transdermal administration of ropinirole and analogs thereof
AU1120097A (en) 1995-12-01 1997-06-27 Alza Corporation Improved method for preventing crystal formation in a dispersion of a liquid in a matrix
JP4205778B2 (ja) 1998-04-17 2009-01-07 久光製薬株式会社 貼付製剤
US20040142024A1 (en) 1999-07-27 2004-07-22 Hisamitsu Pharmaceutical Co., Inc. Patch formulation for external use
ES2286028T3 (es) 1999-07-27 2007-12-01 Hisamitsu Pharmaceutical Co. Inc. Parches para uso externo.
DE10060550C1 (de) 2000-12-06 2002-04-18 Lohmann Therapie Syst Lts Transdermales therapeutisches System mit dem Wirkstoff Oxybutynin und Verfahren zur Herstellung Oxybutynin enthaltender Wirkstoffschichten
US7988991B2 (en) 2001-03-07 2011-08-02 Hisamitsu Pharmaceutical Co., Inc. Adhesive patch
JP4792193B2 (ja) 2002-08-28 2011-10-12 久光製薬株式会社 貼付剤
JP4354678B2 (ja) 2002-08-28 2009-10-28 久光製薬株式会社 貼付剤
US7820145B2 (en) 2003-08-04 2010-10-26 Foamix Ltd. Oleaginous pharmaceutical and cosmetic foam
DE10261696A1 (de) * 2002-12-30 2004-07-15 Schwarz Pharma Ag Vorrichtung zur transdermalen Verabreichung von Rotigotin-Base
US20080038328A1 (en) 2004-05-28 2008-02-14 Naruhito Higo Pasting Preparation
JP5075334B2 (ja) 2004-11-22 2012-11-21 久光製薬株式会社 薬物含有貼付剤
GB0524961D0 (en) 2005-12-07 2006-01-18 Pharmakodex Ltd Transdermal administration of active agents for systemic effect
JP5243254B2 (ja) * 2006-10-11 2013-07-24 久光製薬株式会社 結晶含有貼付剤
US20080226698A1 (en) 2007-03-16 2008-09-18 Mylan Technologies, Inc. Amorphous drug transdermal systems, manufacturing methods, and stabilization
WO2009107478A1 (ja) * 2008-02-27 2009-09-03 久光製薬株式会社 貼付剤及び包装体
JP5485135B2 (ja) 2008-02-27 2014-05-07 久光製薬株式会社 貼付製剤
KR20120024562A (ko) * 2009-04-24 2012-03-14 히사미쓰 세이야꾸 가부시키가이샤 첩부제 수용 포장 백, 및 첩부제의 보존 방법
KR101292768B1 (ko) * 2010-04-23 2013-08-05 아이큐어 주식회사 경피 흡수 제제
EP2564873A4 (en) 2010-04-28 2013-11-06 Hisamitsu Pharmaceutical Co MEANS FOR THE SUPPRESSION OF SKIN IRRITATIONS AND TRANSDERMAL PREPARATION THEREOF
US9155710B2 (en) 2011-05-31 2015-10-13 Hisamitsu Pharmaceutical Co., Inc. Ropinirole-containing patch and package thereof
JPWO2012165254A1 (ja) 2011-05-31 2015-02-23 久光製薬株式会社 ロピニロール含有貼付剤及びその包装体
EP2786752B1 (en) * 2011-12-01 2019-06-12 Teikoku Seiyaku Co., Ltd. Ropinirole-containing adhesive patch
JP5270035B1 (ja) 2012-12-06 2013-08-21 久光製薬株式会社 貼付剤及びその製造方法
JP5307931B1 (ja) 2012-12-27 2013-10-02 久光製薬株式会社 貼付剤及びその製造方法

Also Published As

Publication number Publication date
JP5415645B1 (ja) 2014-02-12
CA2855309A1 (en) 2014-10-16
TWI488644B (zh) 2015-06-21
CN104138366B (zh) 2016-05-11
KR20150002491A (ko) 2015-01-07
CA2855309C (en) 2015-02-17
KR101516122B1 (ko) 2015-04-29
EP2818161A1 (en) 2014-12-31
CN104138366A (zh) 2014-11-12
US9320728B2 (en) 2016-04-26
TW201446268A (zh) 2014-12-16
US20150004215A1 (en) 2015-01-01
JP2015010066A (ja) 2015-01-19
EP2818161B1 (en) 2015-10-07

Similar Documents

Publication Publication Date Title
ES2551459T3 (es) Método para producir un parche de ropinirol supersaturado
CO2019002744A2 (es) Composiciones solubles en agua que comprenden cannabinoides purificadas
CO2017008082A2 (es) Microestructura usando hidrogel de ácido hialurónico reticulado y método para preparar el mismo
MX2020004209A (es) Composiciones y metodos para modular la expresion de la apolipoproteina c-iii.
AR098191A1 (es) Aparato para calentar material fumable
BR112018008915A2 (pt) aparelho ortodôntico com memória de formato contínuo
BR112017023516A2 (pt) composição de polímero reforçado com fibra, e, artigo.
AR088558A1 (es) Sistema que genera aerosol con control mejorado de la produccion de aerosol
TR201903327T4 (tr) Sigara olarak dumanı çekilebilir malzemeyi ısıtmak.
PH12015502208A1 (en) Protective film-forming film and protective film-forming composite sheet
MX2016003123A (es) Sistemas, aparatos y metodos de gestion termica de baterias.
ES2722207T3 (es) Procedimientos para la crioconservación de células epiteliales de pigmento retiniano derivadas de citoblastos crecidas sobre un sustrato polimérico
BR112015020014A2 (pt) estruturas de fechos de contato
PH12016500381A1 (en) Adhesive film and method for manufacturing seminconductor device
WO2014113779A3 (en) Molds for shaping glass and methods for making the same
AR098704A1 (es) Producto de confitería congelado con una cubierta de gel fácilmente despegable y un método para la fabricación del mismo
BR112017017096A2 (pt) ?método de fabricar nano bobina de metal?
CL2017001377A1 (es) Una nueva forma cristalina de un derivado de bencimidazol y un método de preparación de los mismos
FR2973387B1 (fr) Composition polyamide de forte conductivite thermique
BR112016014305B8 (pt) Lenço com gel e método para fabricar um lenço com gel
AR106069A1 (es) Electrodo y proceso para su manufactura
MY176809A (en) High temperature geomembrane liners and master batch compositions
AR096502A1 (es) Proceso para la producción de semilla granulada recubierta
WO2015097347A3 (en) Nanodiamond containing composite and a method for producing the same
CO6650363A2 (es) Preparación recubierta con partículas finas